Harris M - Search Results

1

DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.

Cowan RA, Harris M, Jones M, Crowther D. Cowan RA, et al. Among authors: harris m. Br J Cancer. 1989 Dec;60(6):904-10. doi: 10.1038/bjc.1989.388. Br J Cancer. 1989. PMID: 2605100 Free PMC article.

2

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.

Cowan RA, Jones M, Harris M, Steward WP, Radford JA, Wagstaff J, Deakin DP, Crowther D. Cowan RA, et al. Among authors: harris m. Br J Cancer. 1989 Feb;59(2):276-82. doi: 10.1038/bjc.1989.57. Br J Cancer. 1989. PMID: 2930692 Free PMC article.

3

Prognostic factors in stage I and II high and intermediate grade non-Hodgkin's lymphoma.

Mackintosh JF, Cowan RA, Jones M, Harris M, Deakin DP, Crowther D. Mackintosh JF, et al. Among authors: harris m. Eur J Cancer Clin Oncol. 1988 Oct;24(10):1617-22. doi: 10.1016/0277-5379(88)90054-5. Eur J Cancer Clin Oncol. 1988. PMID: 3208806

4

Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors.

Steward WP, Crowther D, McWilliam LJ, Jones JM, Deakin DP, Todd ID, Blackledge G, Wagstaff J, Scarffe JH, Harris M. Steward WP, et al. Among authors: harris m. Cancer. 1988 Feb 1;61(3):441-7. doi: 10.1002/1097-0142(19880201)61:3<441::aid-cncr2820610306>3.0.co;2-n. Cancer. 1988. PMID: 3338014 Clinical Trial.

5

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

Woll PJ, Crowther D, Johnson PW, Soukop M, Harper PG, Harris M, Brampton MH, Newlands ES. Woll PJ, et al. Among authors: harris m. Br J Cancer. 1995 Jul;72(1):183-4. doi: 10.1038/bjc.1995.299. Br J Cancer. 1995. PMID: 7599050 Free PMC article. Clinical Trial.

6

A doxorubicin-based regimen used in the treatment of elderly patients with high-grade non-Hodgkin's lymphoma.

Wylie JP, Cowan RA, Radford JA, Deakin DP, Harris M, Wilkinson PM. Wylie JP, et al. Among authors: harris m. Clin Oncol (R Coll Radiol). 2000;12(3):153-7. doi: 10.1053/clon.2000.9142. Clin Oncol (R Coll Radiol). 2000. PMID: 10942331

7

Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.

Harris MA, Radford JA, Deakin DP, James RD, Swindell R, Cowan RA. Harris MA, et al. Clin Oncol (R Coll Radiol). 2004 Feb;16(1):53-7. doi: 10.1016/j.clon.2003.08.007. Clin Oncol (R Coll Radiol). 2004. PMID: 14768756

8

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.

Howell SJ, Searle C, Goode V, Gardener T, Linton K, Cowan RA, Harris MA, Hopwood P, Swindell R, Norman A, Kennedy J, Howell A, Wardley AM, Radford JA. Howell SJ, et al. Among authors: harris ma. Br J Cancer. 2009 Aug 18;101(4):582-8. doi: 10.1038/sj.bjc.6605215. Br J Cancer. 2009. PMID: 19672261 Free PMC article.

9

An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.

Ranson MR, Radford JA, Swindell R, Deakin DP, Wilkinson PM, Harris M, Johnson RJ, Crowther D. Ranson MR, et al. Among authors: harris m. Ann Oncol. 1991 Jun;2(6):423-9. doi: 10.1093/oxfordjournals.annonc.a057978. Ann Oncol. 1991. PMID: 1768629 Free article.

10

A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.

Borg-Grech A, Radford JA, Crowther D, Swindell R, Harris M. Borg-Grech A, et al. Among authors: harris m. J Clin Oncol. 1989 Sep;7(9):1303-9. doi: 10.1200/JCO.1989.7.9.1303. J Clin Oncol. 1989. PMID: 2769329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,139 results

Search Page

Filters